Wednesday, 20 November 2002 - 1:30 PM
Hilton San Francisco Franciscan Room D (100)

CESS-192. Innovations in Cessation: Serving the Medicaid Population

Adin C. Miller, MPA, American Legacy Foundation,, Stephen DiGiovanni, MD, Maine Medical Center, Barbara Bush Children's Hospital, Pediatric Office,, Martin C. Mahoney, MD PhD, Roswell Park Cancer Institute, Division of Population Sciences,

Learning Objectives: Recognize specific barriers particular to providing cessation services to Medicaid and low socio-economic status clients. Describe at least three effective methods to overcome these barriers. Compare and contrast at least three comprehensive smoking cessation interventions for a Medicaid population and their preliminary results.

Abstract: Audience: Cessation service providers and tobacco control experts with an interest in low socio-economic status populations will find this panel valuable.

Key Points: This panel will explore three projects funded by the American Legacy Foundation that focus on cessation interventions designed for Medicaid or low-SES clients. The need in this community is tremendous as tobacco use prevalence is higher than the national average. The session will discuss barriers, such as lack of awareness of prescription medication; solutions, including improving documentation of household tobacco use during pediatric office visits; and strategies, to understand the cost-effectiveness of certain approaches.

The projects to be explored include:

Pediatric Partnership for Tobacco Free Families Barbara Bush Children's Hospital at Maine Medical Center - This pilot pediatric office clinical system project seeks to enable pediatricians to improve adherence to the 2000 Public Health Service Clinical Practice Guidelines.

Prenatal Smoking Cessation Program Michigan Public Health Institute - This project will compare the effectiveness of two clinic-based prenatal smoking cessation interventions that target the Medicaid population.

Reducing Barriers to Medications for Smoking Cessation in a Medicaid Population Roswell Park Cancer Institute - This project examines the cost-effectiveness of adjunctive pharmacotherapy for smoking cessation in a Medicaid population through randomized trials.

Educational Experience: The format of the panel will be presentations of each project followed by a 30-40 minute Q&A session.

Benefits: The audience will benefit from the opportunity to compare and contrast current innovations and research in the field and take home new ideas for their own communities.

Back to Innovations in Cessation: Serving the Medicaid Population
Back to Cessation, Nicotine, and the Science of Addiction
Back to The 2002 National Conference on Tobacco or Health